Sector: MedicalEntreMed, Inc. (NASDAQ: ENMD)
Headlines
- EntreMed's ENMD-2076 Active in Solid and Hematological Cancers
Nov 16, 2009 12:30 PM | ENMD
- EntreMed Reports Third Quarter 2009 Financial Results
Nov 16, 2009 07:02 AM | ENMD
- Data for EntreMed's ENMD-2076 to Be Presented at the Upcoming AACR-NCI-EORTC Conference
Nov 03, 2009 07:01 AM | ENMD
- TapImmune Provides Shareholder Update and Review and Acorda Therapeutics to Present at Two Upcoming Conferences
May 02, 2008 01:59 PM | ACOR, ARIA, ENMD
- Economy & Jobs
Jan 03, 2008 10:30 AM | ADP, ANSS, AXTI, CBAK, CGI, CSIQ
- Celgene Reports Record Third Quarter 2009 Operating and Financial Results
Oct 22, 2009 07:51 AM | CELG, ENMD
- EntreMed Reports Second Quarter 2009 Financial Results
Aug 06, 2009 07:01 AM | ENMD
- Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
Jun 01, 2009 07:01 AM | ENMD
- EntreMed ENMD-2076 Phase 1 Data to Be Presented at ASCO Annual Meeting
May 15, 2009 07:01 AM | ENMD
- EntreMed Reports First Quarter 2009 Financial Results
May 06, 2009 07:53 AM | ENMD
- EntreMed Reports Fourth Quarter and Year-End 2008 Financial Results
Mar 12, 2009 07:01 AM | ENMD
- EntreMed Presents Initial Clinical Results for ENMD-2076
Feb 09, 2009 07:01 AM | ENMD
- EntreMed Focuses on Development of ENMD-2076
Dec 15, 2008 12:00 PM | ENMD
- EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma
Dec 09, 2008 07:01 AM | ENMD
- EntreMed to Present at the New York Society of Security Analysts Industry Conference
Nov 25, 2008 07:01 AM | ENMD
- Form 3 ENTREMED INC For: Feb 26 Filed by: Bray Mark R (10K)
Mar 09, 2009 05:31 PM
- Form 4 TARNOW MICHAEL M For: Feb 02 (10K)
Feb 04, 2009 04:54 PM
- Form 4 Wong Cynthia For: Jan 27 (10K)
Jan 29, 2009 02:56 PM
- Form 3 Wehmeir-Davis Kathy For: Dec 15 (10K)
Dec 29, 2008 01:42 PM
- Form 4 Wong Cynthia For: Sep 17 (10K)
Sep 17, 2008 03:21 PM
- Form 4 Burns James S For: Sep 16 (10K)
Sep 17, 2008 11:41 AM
- Form 4 ENTREMED INC For: Jul 10 Filed by: Burns James S (10K)
Jul 14, 2008 08:07 AM
- Form 4 ENTREMED INC For: Jun 18 Filed by: Bliss Thomas H Jr (10K)
Jun 19, 2008 12:05 PM
- Form 3 ENTREMED INC For: Jun 18 Filed by: Bliss Thomas H Jr (10K)
Jun 19, 2008 12:05 PM
- Form 4 ENTREMED INC For: Jun 05 Filed by: RANDALL MARK C M (10K)
Jun 06, 2008 05:15 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ENMD
|
Compare to S&P
|
| YTD |
535.80 %
|
426.20 %
|
| 4 Weeks |
59.05 %
|
57.33 %
|
| 12 Weeks |
98.08 %
|
86.74 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 100.00 %
|
|
EPS Growth in Last Year: 100.00 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: 4.77 %
|
|
